...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

Great news indeed!! assuming the proper partner comes in to pay for it,  my question is if a tree falls in a forest and no one is around to hear it,does it make a sound??   This type of news release if it made  major news outlets across the world which it 100% should based on once going in the world with covid 19 , the stock price would go balistic . My question is why do so little investors , retail, institutional investors , etc know little to  nothing about RVX and its potential to help reduce Covid, this is major news and we'll get zero attention .  Unless something drastic happens to get this attention. 

Share
New Message
Please login to post a reply